Achalasia-microcephaly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:929OMIM:200450Q39.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Achalasia-microcephaly syndrome is an extremely rare genetic disorder characterized by the combination of esophageal achalasia and microcephaly (an abnormally small head circumference). Achalasia is a motility disorder of the esophagus in which the lower esophageal sphincter fails to relax properly during swallowing, leading to difficulty swallowing (dysphagia), regurgitation, and failure to thrive. Microcephaly in this syndrome is associated with intellectual disability of variable severity. The condition primarily affects the gastrointestinal system and the central nervous system. Additional features that have been reported in some affected individuals include short stature and other developmental abnormalities. The syndrome typically presents in infancy or early childhood, when feeding difficulties and poor weight gain become apparent alongside recognition of reduced head growth. The condition has been described in a very small number of families, with reports suggesting autosomal recessive inheritance based on occurrence in siblings born to unaffected parents, sometimes with parental consanguinity. Treatment is symptomatic and supportive. Management of achalasia may involve pneumatic dilation of the lower esophageal sphincter or surgical myotomy (Heller myotomy) to improve esophageal emptying and feeding. Nutritional support is important to address failure to thrive. Developmental and educational interventions are recommended for intellectual disability. There is currently no cure or disease-modifying therapy for this syndrome, and long-term management requires a multidisciplinary approach involving gastroenterology, neurology, and developmental specialists.

Clinical phenotype terms— hover any for plain English:

AchalasiaHP:0002571
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Achalasia-microcephaly syndrome.

View clinical trials →

No actively recruiting trials found for Achalasia-microcephaly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Achalasia-microcephaly syndrome community →

No specialists are currently listed for Achalasia-microcephaly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Achalasia-microcephaly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Achalasia-microcephaly syndromeForum →

No community posts yet. Be the first to share your experience with Achalasia-microcephaly syndrome.

Start the conversation →

Latest news about Achalasia-microcephaly syndrome

No recent news articles for Achalasia-microcephaly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Achalasia-microcephaly syndrome

What is Achalasia-microcephaly syndrome?

Achalasia-microcephaly syndrome is an extremely rare genetic disorder characterized by the combination of esophageal achalasia and microcephaly (an abnormally small head circumference). Achalasia is a motility disorder of the esophagus in which the lower esophageal sphincter fails to relax properly during swallowing, leading to difficulty swallowing (dysphagia), regurgitation, and failure to thrive. Microcephaly in this syndrome is associated with intellectual disability of variable severity. The condition primarily affects the gastrointestinal system and the central nervous system. Additiona

How is Achalasia-microcephaly syndrome inherited?

Achalasia-microcephaly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Achalasia-microcephaly syndrome typically begin?

Typical onset of Achalasia-microcephaly syndrome is infantile. Age of onset can vary across affected individuals.